What is DIANOSIC SAS?
Founded in 2017 and headquartered in France, DIANOSIC SAS is a deeptech company specializing in solutions for Ear, Nose, and Throat (ENT) conditions. The company leverages advanced technology to address unmet needs within this medical specialty, positioning itself as an innovator in the healthcare technology landscape. Its focus on a specific medical niche, combined with its deeptech foundation, indicates a strategy centered on specialized innovation and targeted market penetration.
How much funding has DIANOSIC SAS raised?
DIANOSIC SAS has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2023): $5M with participation from Bpifrance and WiSEED
Key Investors in DIANOSIC SAS
Bpifrance
Bpifrance is a French public investment bank that finances companies at every stage of their development, supporting innovation, international expansion, and export activities.
WiSEED
WiSEED is a French crowdfunding platform that enables private investors to directly invest in innovative and technological startups, offering a new investment horizon.
What's next for DIANOSIC SAS?
With the recent influx of capital, DIANOSIC SAS is strategically positioned to advance its product development, expand its market reach, and potentially scale its operations. The major strategic investment signals confidence from its backers in the company's long-term vision and its capacity to innovate within the ENT sector. Future endeavors will likely focus on translating this investment into tangible growth, further solidifying its position in the competitive healthcare technology market.
See full DIANOSIC SAS company page
